June 2, 2025 | RWO, Real World Outcomes

Medscape Education has recently published a study looking at the real-world impact of online continuing medical education on Alzheimer’s disease diagnosis.
The study, published in JMIR Medical Education, looks at the impact of Medscape’s online education in Alzheimer’s disease using Real-World Outcomes. The results showed a significant increase in the volume of Alzheimer’s diagnoses (F1900 = 5.50; P = .02) following Medscape’s online CME, resulting in several thousand more estimated diagnoses annually.
“A timely diagnosis of Alzheimer’s disease makes a real difference to patients’ and caregivers’ lives. This study found CME learners’ increase in new diagnoses was 1.6 times greater than nonlearners’, leading to an estimated 7939 new diagnoses annually. This study highlights rigorous evaluation of Medscape’s CME and the power of our online education to drive meaningful differences in real-world patient care,” said Medscape Education Chief Impact Officer Katie Lucero, PhD.
Medscape Education has a commitment to publishing the outcomes and impact of their education in leading journals and at medical conferences around the world. Medscape Education published 145 studies, posters, abstracts, and other publications in 2024.
For more information on Medscape’s Real-World Outcomes please fill out this form here.
About Medscape Education
Medscape Education (medscape.org) is the leading destination for continuous professional development, consisting of more than 30 specialty-focused destinations offering thousands of free accredited CME and CE courses for physicians, nurses, and other healthcare professionals
This content was provided by Medscape Education
Company Details
Latest Content from Medscape Education
For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven…
In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical…
A February Focus on the Heart While February is known as the month of love, it is also National Heart Month, a time for highlighting the importance of cardiovascular health….
Join the Medscape team in Atlanta, February 16–19, 2026, as Alliance celebrates 50 years of excellence in continuing education for health professionals. We’re bringing our 3 decades of experience in…
While obstructive sleep apnea (OSA) affects approximately 32% of US adults—nearly 80 million people—it remains an “epidemic hiding in plain sight”. Perhaps most staggering is that 90% of women with…
For decades, modern medicine has treated the mouth and the body as separate entities. But for Dr. Nieca Goldberg, a renowned cardiologist, and Dr. Maria Ryan, Chief Clinical Officer at…
On December 5, MAPS hosted an educational webinar exploring recent research in Alzheimer’s disease (AD) screening, testing, and treatment. Experts from Komodo Health and Medscape shared findings from their…
Discover how AI-powered tools are transforming rare disease diagnosis, patient care, and clinical decision-making.
For a child with a rare disease, a doctor’s continuing education can end a years-long diagnostic odyssey and unlock access to vital care.
How was a new rare disease discovered through Singapore’s Undiagnosed Disease Program? And how will technology allow us to change how we discover rare diseases in the future? Read more…
